Pharmaceutical PV DIV - FSB
Ended Awarded Last action
- Contract number
- SPE2DU26FF001
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $21,024
Award facts
- Contract value 100% obligated
- $21,024.20 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order valued at $21,024.20 to AmerSourceBergen Drug Corp, a subsidiary of Cencora, Inc., on January 23, 2026, with an ultimate completion date of February 13, 2026. This firm fixed-price delivery order is non-competitive, as it was issued under AmerSourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.99 billion master contract running through December 2026. The contract is performed at the awardee's corporate office location in Conshohocken, Pennsylvania, and represents a task order for pharmaceutical products and medical supplies supporting military healthcare operations.
AmerSourceBergen Drug Corp, as the prime contractor through its parent company Cencora, Inc., is a major pharmaceutical distributor providing critical medical commodities to federal agencies, particularly the Department of Defense and Defense Health Agency. The SPE2DX IDC under which this delivery order falls is designed to supply a comprehensive range of pharmaceutical products, including specialty medications, brand-name and generic drugs, vaccines, and related medical supplies to military treatment facilities and veteran healthcare programs globally. This delivery order exemplifies the routine procurement activity conducted under DLA's pharmaceutical prime vendor program, which ensures consistent availability of essential medical products across the federal military healthcare supply chain.
Quick answers
Who was awarded contract SPE2DU26FF001?
SPE2DU26FF001 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 23, 2026.
How much is contract SPE2DU26FF001 worth?
The government has obligated $21,024 on SPE2DU26FF001.
Is contract SPE2DU26FF001 an order under another contract?
Yes. SPE2DU26FF001 is a delivery order under SPE2DU25D5117, an indefinite delivery contract.
Was contract SPE2DU26FF001 competed?
The extent of competition for SPE2DU26FF001 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award